Evert J. van Elk

Amyloid-β(1–42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease

Cees Mulder, Nicolaas A. Verwey, Wiesje M. van der Flier et al. · Clinical Chemistry · 2009 · 342 citations · Full text

Amyloid β(1–42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease

Niki S.M. Schoonenboom, Yolande A.L. Pijnenburg, Cees Mulder et al. · Neurology · 2004 · 180 citations

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment

Femke H. Bouwman, S.N.M. Schoonenboom, Wiesje M. van der Flier et al. · Neurobiology of Aging · 2006 · 179 citations

Neurodegenerative Diseases, Neuropsychology, Alzheimer's Disease +10

CSF biomarkers predict rate of cognitive decline in Alzheimer disease

Maartje I. Kester, Annelies E. van der Vlies, Marinus A. Blankenstein et al. · Neurology · 2009 · 163 citations

CSF biomarker levels in early and late onset Alzheimer's disease

Femke H. Bouwman, Niki S.M. Schoonenboom, Nicolaas A. Verwey et al. · Neurobiology of Aging · 2008 · 141 citations

Alzheimer's Disease, Csf Biomarker Levels, Dementia +10